The FDA initiates several types of injunctions, which are authorized by Section 302 of the FD&C Act. These types of injunctions are:
A. Temporary restraining order, post marketing and permanent
B. Clinical investigator disqualification, inspection findings and warning letters
C. Clinical investigator disqualification, no publicity, and warning letters
D. Temporary restraining order, preliminary, and permanent
